Exosomal Transfer of DNA Methyl-Transferase mRNA Induces an Immunosuppressive Phenotype in Human Monocytes

Jon R Wisler1, Kanhaiya Singh2, Adara McCarty1

  • 1Division of Trauma and Critical Care, Department of Surgery, Ohio State University, Columbus, Ohio.

Shock (Augusta, Ga.)
|June 27, 2022
PubMed
Abstract

Insights

Sepsis survivors show immune suppression due to exosome transfer of DNA methyltransferase (DNMT) mRNAs to monocytes. Targeting this process may restore immune function.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cell Biology

Background:

  • Sepsis survivors experience prolonged immunosuppression, potentially linked to epigenetic alterations.
  • Circulating exosomes during sepsis carry significant amounts of DNA methyltransferase (DNMT) messenger RNAs (mRNAs).

Purpose of the Study:

  • To investigate if exosomes transfer DNMT mRNAs to monocytes, causing methylation and immunosuppression.
  • To explore the therapeutic potential of targeting exosome-mediated epigenetic changes in sepsis.

Main Methods:

  • Monocytes were stimulated with lipopolysaccharide (LPS) to generate exosomes containing DNMT mRNA.
  • Exosome uptake kinetics were analyzed using confocal microscopy and pharmacologic inhibitors.
  • DNMT mRNA expression and packaging were modulated using small interfering RNAs (siRNAs).
  • DNA methylation patterns were assessed via bisulfite sequencing; pathway analysis identified significant methylated regions.

Main Results:

  • Exosomes successfully transferred DNMT mRNA to recipient monocytes, increasing their expression.
  • Inhibiting exosome uptake prevented DNMT mRNA transfer and subsequent hypermethylation and gene suppression.
  • siRNAs reduced DNMT mRNA packaging, prevented tumor necrosis factor-alpha (TNFα) gene suppression, and restored immunocompetence.

Conclusions:

  • Exosomes mediate the transfer of DNMT mRNA, leading to DNA methylation and gene silencing.
  • Inhibiting exosome uptake or DNMT mRNA transfer preserves TNFα expression and immune response.
  • Targeting exosome-mediated epigenetic events offers a potential therapeutic strategy for sepsis-induced immunosuppression.